A journal article explores mothers’ perceptions of the importance of health and health care during pregnancy and postpartum and their preferences for communication from a community-based service program.
Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
This study finds that Maryland's all-payer model for healthcare comparatively lowered the risk of complications from surgery, as well as reducing increases in associated costs.
Anaeze C. Offodile II, Oluseyi Aliu, Andrew W. P. Lee, Jonathan E. Efron, Robert S. D. Higgins, Charles ButlerSeptember 28, 2021
The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal
Anaeze C. Offodile II, Chris Sidey-Gibbons, André Pfob, Malke Assad, Stefanos Boukovalas, Yu-Li Lin, Jesse Creed Selber, Charles ButlerMarch 26, 2021
Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.
Sayna Norouzi, Bo Zhao, Ahmed Awan, Wolfgang Winkelmayer, Vivian Ho, Kevin EricksonFebruary 5, 2020
This study assesses the state of stem cell research in the Greater Middle East, reports on the policy and ethical considerations facing the region, and determines the impact of international research collaborations in this area.
Jesse M. Flynn, Kirstin R.W. MatthewsMarch 3, 2010